DK149810C - Analogifremgangsmaade til fremstilling af basisk substituerede 3-oxopyridaziner og deres fysiologisk acceptable syreadditionssalte - Google Patents

Analogifremgangsmaade til fremstilling af basisk substituerede 3-oxopyridaziner og deres fysiologisk acceptable syreadditionssalte

Info

Publication number
DK149810C
DK149810C DK542881A DK542881A DK149810C DK 149810 C DK149810 C DK 149810C DK 542881 A DK542881 A DK 542881A DK 542881 A DK542881 A DK 542881A DK 149810 C DK149810 C DK 149810C
Authority
DK
Denmark
Prior art keywords
addition salts
alkoxy
oxopyridazines
analogue
preparation
Prior art date
Application number
DK542881A
Other languages
Danish (da)
English (en)
Other versions
DK542881A (da
DK149810B (da
Inventor
Thomas Raabe
Helmut Bohn
Piero A Martorana
Rolf-Eberhard Nitz
Original Assignee
Cassella Farbwerke Mainkur Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Farbwerke Mainkur Ag filed Critical Cassella Farbwerke Mainkur Ag
Publication of DK542881A publication Critical patent/DK542881A/da
Publication of DK149810B publication Critical patent/DK149810B/da
Application granted granted Critical
Publication of DK149810C publication Critical patent/DK149810C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22Nitrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Pyridine Compounds (AREA)
DK542881A 1980-12-22 1981-12-08 Analogifremgangsmaade til fremstilling af basisk substituerede 3-oxopyridaziner og deres fysiologisk acceptable syreadditionssalte DK149810C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3048487 1980-12-22
DE19803048487 DE3048487A1 (de) 1980-12-22 1980-12-22 Basisch substituierte pyridazine, ihre herstellung und ihre verwendung

Publications (3)

Publication Number Publication Date
DK542881A DK542881A (da) 1982-06-23
DK149810B DK149810B (da) 1986-10-06
DK149810C true DK149810C (da) 1987-03-23

Family

ID=6119960

Family Applications (1)

Application Number Title Priority Date Filing Date
DK542881A DK149810C (da) 1980-12-22 1981-12-08 Analogifremgangsmaade til fremstilling af basisk substituerede 3-oxopyridaziner og deres fysiologisk acceptable syreadditionssalte

Country Status (26)

Country Link
US (1) US4532239A (fr)
EP (1) EP0054946B1 (fr)
JP (1) JPS57128677A (fr)
KR (1) KR880002233B1 (fr)
AT (1) ATE8991T1 (fr)
AU (1) AU544386B2 (fr)
CA (1) CA1173033A (fr)
CS (1) CS236665B2 (fr)
DD (1) DD202013A5 (fr)
DE (2) DE3048487A1 (fr)
DK (1) DK149810C (fr)
ES (3) ES508274A0 (fr)
FI (1) FI73418C (fr)
GR (1) GR81382B (fr)
HK (1) HK51485A (fr)
IE (1) IE51985B1 (fr)
IL (1) IL64605A (fr)
NO (1) NO814182L (fr)
NZ (1) NZ198919A (fr)
PH (1) PH17529A (fr)
PL (3) PL137106B1 (fr)
PT (1) PT74185B (fr)
RO (3) RO88190B (fr)
SG (1) SG7585G (fr)
SU (2) SU1170970A3 (fr)
ZA (1) ZA818806B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3023369A1 (de) * 1980-06-23 1982-01-14 Boehringer Mannheim Gmbh, 6800 Mannheim Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPH0641454B2 (ja) * 1985-02-27 1994-06-01 日産化学工業株式会社 ピリダジノン誘導体
US4892947A (en) * 1985-04-27 1990-01-09 Nissan Chemical Industries Ltd. 3(2H)Pyridazinone, process for its preparation and anti-allergic agent containing it
JPS61282194A (ja) * 1985-06-06 1986-12-12 Yukio Nakamura ジエツト推進式舟艇の推進軸とその製造法
JPH0629254B2 (ja) * 1986-09-08 1994-04-20 帝国臓器製薬株式会社 ピリダジノン誘導体
DE3902316A1 (de) * 1989-01-26 1990-08-02 Lentia Gmbh Neue piperazinylalkyl-3(2h)-pyridazinone, verfahren zu ihrer herstellung und ihre verwendung als blutdrucksenkende mittel
NZ234087A (en) * 1989-06-19 1991-08-27 Teikoku Hormone Mfg Co Ltd 2-(3-aryloxy(2-hydroxy-propylamino))-2-methylpropyl- aminophenyl pyridazine derivatives
US5221674A (en) * 1989-06-19 1993-06-22 Teikoku Hormone Mfg. Co., Ltd. Pyridazinone derivatives
HU214320B (hu) * 1991-12-20 1998-03-02 EGIS Gyógyszergyár Rt. Eljárás új 3(2H)-piridazinon-származékok és ezeket tartalmazó gyógyszerkészítmények előállítására
BR9815967A (pt) * 1998-06-05 2004-06-22 Egyt Gyogyszervegyeszeti Gyar Processo para a preparação de um derivado de amino-5-cloro de 3(2h)-piridazinona-4-substituìdo
MX2009009948A (es) * 2007-03-15 2009-09-24 Schering Corp Derivados de piridazinona utiles como inhibidores de glucano sintasa.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA957364A (en) * 1968-11-18 1974-11-05 Pfizer Corporation Preparation of polar-substituted phenyl propanolamines
GB1421999A (en) * 1973-02-08 1976-01-21 Smith Kline French Lab Heterocyclic containing sulphoxides
US4115575A (en) * 1973-02-20 1978-09-19 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-pyrazines
GB1488330A (en) * 1973-12-19 1977-10-12 Smith Kline French Lab Dihydropyridazinones
US4088764A (en) * 1973-12-27 1978-05-09 Cassella Farbwerke Mainkur Aktiengesellschaft Pharmaceutically active derivatives of 1-phenoxy-3-amino-propan-2-ol
CH591448A5 (fr) * 1974-05-14 1977-09-15 Ciba Geigy Ag
LU77339A1 (fr) * 1977-05-16 1979-01-19
DD146749A3 (de) * 1977-12-01 1981-03-04 Dieter Lehmann Verfahren zur herstellung von phenoxyalkanolamin-derivaten
DE3023369A1 (de) * 1980-06-23 1982-01-14 Boehringer Mannheim Gmbh, 6800 Mannheim Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
RO88190B (ro) 1985-12-31
ES8304941A1 (es) 1983-03-16
ES518138A0 (es) 1983-10-16
PL136127B1 (en) 1986-01-31
RO84277A (fr) 1984-05-23
NO814182L (no) 1982-06-23
PL137150B1 (en) 1986-05-31
FI73418B (fi) 1987-06-30
DD202013A5 (de) 1983-08-24
RO84277B (ro) 1984-07-30
SU1151204A3 (ru) 1985-04-15
ES518139A0 (es) 1983-10-01
IL64605A0 (en) 1982-03-31
ES8308859A1 (es) 1983-10-01
SG7585G (en) 1985-08-08
ES8400096A1 (es) 1983-10-16
PL137106B1 (en) 1986-04-30
PL234312A1 (en) 1983-02-14
JPS57128677A (en) 1982-08-10
CA1173033A (fr) 1984-08-21
IL64605A (en) 1985-11-29
DK542881A (da) 1982-06-23
NZ198919A (en) 1985-05-31
DE3048487A1 (de) 1982-07-29
AU7870481A (en) 1982-07-01
SU1170970A3 (ru) 1985-07-30
RO88201A (fr) 1985-12-30
RO88201B (ro) 1985-12-31
ES508274A0 (es) 1983-03-16
EP0054946A1 (fr) 1982-06-30
EP0054946B1 (fr) 1984-08-15
ATE8991T1 (de) 1984-09-15
AU544386B2 (en) 1985-05-23
PT74185A (de) 1982-01-01
ZA818806B (en) 1982-11-24
RO88190A (fr) 1985-12-30
DK149810B (da) 1986-10-06
PH17529A (en) 1984-09-13
GR81382B (fr) 1984-12-11
DE3165595D1 (en) 1984-09-20
CS236665B2 (en) 1985-05-15
KR880002233B1 (ko) 1988-10-20
KR830007577A (ko) 1983-11-04
PL238537A1 (en) 1983-06-20
US4532239A (en) 1985-07-30
PT74185B (de) 1987-03-24
IE51985B1 (en) 1987-05-13
PL238538A1 (en) 1983-04-25
FI73418C (fi) 1987-10-09
HK51485A (en) 1985-07-12
FI813941L (fi) 1982-06-23
IE813014L (en) 1982-06-22

Similar Documents

Publication Publication Date Title
DK611686D0 (da) Pyrazolinderivater, fremgangsmaade til fremstilling deraf og deres anvendelse som middel med insekticid og akaricid virkning
DK149810C (da) Analogifremgangsmaade til fremstilling af basisk substituerede 3-oxopyridaziner og deres fysiologisk acceptable syreadditionssalte
DK202882A (da) Fremgangsmaade til fremstilling af 1-alkyl-2-aminotetralinderivater
SE8501895L (sv) Fenetanolaminforeningar
DK339184A (da) Imidazoliumforbindelser, mellemprodukter hertil og fremgangsmaade til deres anvendelse
IE782041L (en) Xanthine derivatives having antiallergic activity
DE69721838D1 (de) 1-[1-(4-chlorphenyl)cyclobutyl]-3-methylbutyl amin derivate zur senkung von harnsäurespiegeln beim menschen
ATE173252T1 (de) Arylmorpholine, herstellung und verwendung
DK42481A (da) Fremgangsmaade til fremstilling af piperazinderivater af theophyllin
ATE44875T1 (de) 4-amino-2-(imidazolidin-2-on-l-yl)-pyrimidin-5carbons|ure-(n-(3-trifluormethyl-phenyl)-amide) zur antithrombotischen prophylaxe und behandlung sowie ihre verwendung zur herstellung von antithrombotisch wirksamen arzneimitteln.
ES8705405A1 (es) Procedimiento de preparar nuevos derivados morfolinicos
ES517108A0 (es) Procedimiento para la preparacion de nuevas 1-furil-3,4-dihidroisoquinoleinas.
DK549085A (da) 3-aminopropoxyphenylderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater, som indeholder disse derivater
SE8500962D0 (sv) Nitrodiaryl sulfoxide derivatives, process for their preparation and pharmaceutical and pesticidal compositions containing them as active ingredient

Legal Events

Date Code Title Description
PBP Patent lapsed